Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies
- 7 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 258 (10), 1812-1819
- https://doi.org/10.1007/s00415-011-6021-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Modeling disease-state transition heterogeneity through Bayesian variable selectionStatistics in Medicine, 2009
- How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?Neurology, 2007
- Predicting short-term disability in multiple sclerosisNeurology, 2007
- A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB studyAutoimmunity Reviews, 2006
- United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlatesMultiple Sclerosis Journal, 2001
- Nonparametric Two-Sample Comparisons of Changes on Ordinal ResponsesJournal of the American Statistical Association, 1999
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Sample size calculations for ordered categorical dataStatistics in Medicine, 1993
- Neuroepidemiology. Part II: Assessment of therapeutic trialsAnnals of Neurology, 1986
- Rating neurologic impairment in multiple sclerosisNeurology, 1983